DIN 00392693 — ATROPINE SULFATE INJECTION USP .6 MG
ATROPINE SULFATE INJECTION USP is a solution of Atropine marketed by SANDOZ CANADA INCORPORATED. The full Atropine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 00392693
- Brand name
- ATROPINE SULFATE INJECTION USP
- Active ingredient
- Atropine
- Strength
- .6 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Anticholinergic (antimuscarinic) agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atropine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00035017 | ALCON ATROPINE | 1 % | SOLUTION | ALCON CANADA INC | MARKETED |
| 02023695 | ATROPINE | 1 % | SOLUTION | PHARMA STULLN INC. | MARKETED |
| 02432188 | ATROPINE INJECTION BP | 0.4 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED |
| 02432196 | ATROPINE INJECTION BP | 0.6 MG | SOLUTION | HIKMA CANADA LIMITED | MARKETED |
| 02426269 | ATROPINE SULFATE INJECTION | 0.5 MG | SOLUTION | LABORATOIRE AGUETTANT | MARKETED |
| 02426277 | ATROPINE SULFATE INJECTION | 1 MG | SOLUTION | LABORATOIRE AGUETTANT | MARKETED |
| 00392782 | ATROPINE SULFATE INJECTION USP | 0.4 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02148358 | MINIMS ATROPINE SULPHATE | 1 % | DROPS | BAUSCH & LOMB INC | MARKETED |